Edit
Avanir Pharmaceuticals
http://www.avanir.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 30.10.2020
Active
Our passionate team of thinkers is working to alleviate the burdens of those affected by central nervous conditions.
Location: United States, California, Aliso Viejo
Total raised: $30M
Founded date: 1988
Investors 2
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.06.2012 | - | $30M | - |
Mentions in press and media 9
| Date | Title | Description |
| 30.10.2020 | Avanir Pharmaceuticals Named One of Orange County's Best Places to Work | |
| 15.07.2015 | New drug delivery methods are making taking medicine easier for everyone | Three dimensional printing technology is becoming more and more popular, from creating prosthetics to artificial organs. That same technology is also being used to create a new way to deliver medication. Aprecia Pharmaceuticals in Langhorne... |
| 04.12.2014 | West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Where is biotech innovation? All over, we would contend, but according to The Scientist magazine, San Diego has been an especially good place to look this year. The publicatio... |
| 03.07.2013 | Intranasal drug delivery disruptor OptiNose signs licensing deal for migraine treatment | A company that’s poised to disrupt the nasal drug delivery market has signed a licensing deal with Avanir Pharmaceuticals (Nasdaq: AVNR) valued at $110 million. OptiNose’s drug delivery system in Phase 3 development to treat migraine headac... |
| 26.06.2012 | Avanir Pharmaceuticals Receives $30M Debt Facility | Avanir Pharmaceuticals, Inc., an Aliso Viejo, CA-based biopharmaceutical company focused on bringing medicines to patients with central nervous system disorders, has received a $30m debt facility. The financing was led by Oxford Finance LLC... |
| 22.06.2012 | Avanir Pharmaceuticals Gets $30M In Credit Facility | Aliso Viejo-based Avanir Pharmaceuticals, the biopharmaceuticals firm focused on treatments for central nervous system disorders, has received $30M in a debt funding round, according to lenders Oxford FInance and Silicon Valley Bank. Avanir... |
| 27.03.2008 | AVANIR Gets $40M In PIPE | Aliso Viejo-based AVANIR Pharmaceuticals said this morning that it has raised $40M in a registered direct offering from its venture investors. The funding was led by ProQuest Investments, and also included Clarus Ventures, Vivo Ventures, an... |
| - | New drug delivery methods are making taking medicine easier for everyone | Whether it’s a child unable to swallow a pill or someone who has a strong fear of needles, getting the right medication to the right person can sometimes be a bit more difficult than you think it should be. Needle fearers and anti-pill advo... |
| - | Intranasal drug delivery disruptor OptiNose signs licensing deal for migraine treatment | A company that’s poised to disrupt the nasal drug delivery market has signed a licensing deal with Avanir Pharmaceuticals (Nasdaq: AVNR) valued at $110 million. OptiNose’s drug delivery system in Phase 3 development to treat migraine headac... |